<DOC>
	<DOCNO>NCT01295294</DOCNO>
	<brief_summary>The purpose study investigate study drug ( tranexamic acid mefenamic acid ) control irregular bleeding first 3 month use Mirena . The study drug test test placebo ( `` dummy medication contain active drug '' ) . Treatment period follow one-month period study drug take Mirena use continue .</brief_summary>
	<brief_title>Management Initial Bleeding/Spotting Associated With Levonorgestrel-releasing Intrauterine System ( MIRENA )</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<mesh_term>Mefenamic Acid</mesh_term>
	<criteria>Signed date informed consent Healthy female subject request contraception Age : 18 45 year inclusive Successful interval insertion MIRENA History regular cyclic menstrual period Normal clinically insignificant cervical smear require follow Pregnancy lactation Climacteric symptom prior screen visit Known suspect clinically significant ovarian cyst , endometrial polyp , fibroid , genital organ pathology , , opinion investigator , may interfere assessment bleed profile study Undiagnosed abnormal genital bleed Current history thrombembolic disease , establish risk factor venous thromboembolism Current migraine , focal migraine asymmetrical visual loss symptom indicate transient cerebral ischemia , exceptionally severe headache Hypersensitivity ingredient investigational medicinal product noninvestigational medicinal product Daily frequent use nonsteroidal antiinflammatory drug ( NSAIDs ) condition Not willing use nonsteroidal antiinflammatory drug ( NSAIDs ) medication pain medication double blind treatment period</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Uterine Hemorrhage</keyword>
	<keyword>Contraception</keyword>
	<keyword>Contraceptive Methods</keyword>
	<keyword>Intrauterine device</keyword>
	<keyword>Mirena</keyword>
</DOC>